Enfusion, Inc. (ENFN)
Market Cap | 1.27B |
Revenue (ttm) | 195.16M |
Net Income (ttm) | 2.73M |
Shares Out | 128.57M |
EPS (ttm) | 0.03 |
PE Ratio | 328.27 |
Forward PE | 36.92 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 406,208 |
Open | 9.60 |
Previous Close | 9.64 |
Day's Range | 9.60 - 9.99 |
52-Week Range | 7.52 - 10.45 |
Beta | 0.93 |
Analysts | Sell |
Price Target | 9.00 (-9.0%) |
Earnings Date | Nov 4, 2024 |
About ENFN
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, an... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 4 analysts, the average rating for ENFN stock is "Sell." The 12-month stock price forecast is $9.0, which is a decrease of -9.00% from the latest price.
News
Enfusion To Present at Upcoming Investor Events
NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced that Enf...
Enfusion, Inc. (ENFN) Q3 2024 Earnings Call Transcript
Enfusion, Inc. (NYSE:ENFN) Q3 2024 Earnings Conference Call November 4, 2024 8:30 AM ET Company Participants Bill Wright - Head, IR Oleg Movchan - Chief Executive Officer Bradley Herring - Chief Fina...
Enfusion Announces Third Quarter 2024 Results
NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, has posted its third qua...
Enfusion Announces Key Leadership Team Additions to Drive Client Success and Fuel Innovation
NEW YORK--(BUSINESS WIRE)--Enfusion, Inc. (“Enfusion”) (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, announced today the appointments of Arman Art...
FTV Capital and One Mind at Work Launch Partnership to Support Mental Health Within High-Growth Companies
SAN FRANCISCO & RUTHERFORD, Calif.--(BUSINESS WIRE)--FTV Capital, a leading sector-focused growth equity firm, and One Mind at Work, a global nonprofit dedicated to building the future of workforce me...
Enfusion Announces Date of Third Quarter 2024 Results
NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced it will ...
The Schall Law Firm Invites Investor Participation In An Inquiry Into Enfusion Inc For Violating Securities Laws
LOS ANGELES, CA / ACCESSWIRE / October 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, Inc. ...
Enfusion, Inc. Is Being Looked Into For Possible Securities Fraud And Affected Shareholders Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / October 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, Inc. ...
The Schall Law Firm Invites Investors To Help Investigate Whether Enfusion Inc Violated Securities Laws
LOS ANGELES, CA / ACCESSWIRE / September 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, In...
Shareholders Are Encouraged To Join The Schall Law Firm's Inquiry Into Enfusion, Inc. For Possible Securities Fraud
LOS ANGELES, CA / ACCESSWIRE / September 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, In...
Enfusion Inc Is Being Investigated For Violating Securities Laws And The Schall Law Firm Seeks Investor Participation
LOS ANGELES, CA / ACCESSWIRE / September 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, In...
The Schall Law Firm Is Inquiring Into Enfusion, Inc. For Possible Securities Fraud And Stockholders With Losses Should Take Part
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, Inc. ("Enfusion" or "the Company") (NYSE:ENFN) for vio...
Enfusion Inc May Have Violated Securities Laws And The Schall Law Firm Wants Impacted Investors To Reach Out
LOS ANGELES, CA / ACCESSWIRE / September 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, In...
Shareholders Are Urged To Join The Schall Law Firm's Investigation Into Enfusion, Inc. For Possible Securities Fraud
LOS ANGELES, CA / ACCESSWIRE / September 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, In...
VALD Secures Significant Growth Equity Investment from FTV Capital
BRISBANE, Australia--(BUSINESS WIRE)--VALD, a global health technology company and the system of choice for musculoskeletal (“MSK”) health professionals, today announced a significant growth equity in...
Enfusion Inc Is Being Looked Into For Violating Securities Laws And The Schall Law Firm Invites Investors To Reach Out
LOS ANGELES, CA / ACCESSWIRE / September 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, In...
The Schall Law Firm Is Investigating Enfusion, Inc. For Possible Securities Fraud And Affected Shareholders Are Urged To Lend A Hand
LOS ANGELES, CA / ACCESSWIRE / September 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, In...
Enfusion Inc May Have Violated Securities Laws And The Schall Law Firm Wants Investors With Losses To Help With An Inquiry
LOS ANGELES, CA / ACCESSWIRE / September 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, In...
The Schall Law Firm Is Looking Into Enfusion, Inc. For Possible Securities Fraud And Shareholders Are Urged To Take Part
LOS ANGELES, CA / ACCESSWIRE / September 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, In...
Exclusive: Financial software maker Enfusion explores options including sale, sources say
Enfusion , a U.S. software provider for asset managers, is in talks with investment bankers to evaluate its options that could include a potential sale, according to people familiar with the matter.
Enfusion Inc May Have Violated Securities Regulations And The Schall Law Firm Encourages Investor Participation In An Inquiry
LOS ANGELES, CA / ACCESSWIRE / September 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, In...
The Schall Law Firm Is Looking Into Enfusion, Inc. For Possible Securities Fraud And Affected Stockholders Are Urged To Reach Out
LOS ANGELES, CA / ACCESSWIRE / September 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, In...
Enfusion Inc May Have Violated Securities Laws And Investors With Losses Can Join The Schall Law Firm's Investigation
LOS ANGELES, CA / ACCESSWIRE / September 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, In...
The Schall Law Firm Is Inquiring Into Enfusion, Inc. For Possible Securities Fraud And Shareholder Participation Is Urged
LOS ANGELES, CA / ACCESSWIRE / September 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, In...
Enfusion Inc May Have Violated Securities Laws And Investors With Losses Should Join The Schall Law Firm's Investigation
LOS ANGELES, CA / ACCESSWIRE / September 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, In...